Myotonic Dystrophy (DM)

Myotonic dystrophy, also called Steinert disease, is a form of muscular dystrophy that affects muscles and many other organs in the body.

Blog Post

Clinical Trial Alert: Expansion Therapeutics Seeks Participants for a Phase 1 DM1 Study

By MDA Staff | February 18, 2020
Blog Post

MDA Grants Charles Thornton More Than $1 Million in New Funding to Continue Supporting the Myotonic Dystrophy Clinical Research Network

By Jeanene Swanson | October 25, 2019
Blog Post

MDA Awards 25 Grants Totaling More Than $6.6 Million for Neuromuscular Disease Research

By Jeanene Swanson | September 5, 2019
Blog Post

“How Muscular Dystrophy Changed my Life”: A Diagnosis that Led to an Incredible Cross-Country Journey

By Jon Olson | August 21, 2019
Featured Article

Guiding Treatment for Myotonic Dystrophy

By MDA Staff | July 15, 2019
Featured Article

The State of Gene Targeted Therapies

By Jeanene Swanson | July 15, 2019
Blog Post

2019 Clinical & Scientific Conference Highlight: What’s New in Neuromuscular Diseases?

By Jeanene Swanson | July 10, 2019
Blog Post

2019 Clinical & Scientific Conference Highlight: Neuromuscular Disease Impacts Cognition and Behavior, Too

By Ori Rokach | July 9, 2019
Blog Post

The Christopher Project Report to the Myotonic Dystrophy Community is Now Available

By Jeanene Swanson | July 5, 2019
Blog Post

MDA Awards Venture Philanthropy Funding to Locana to Develop Novel Treatment for DM

By Jeanene Swanson | June 12, 2019